ARCHIVES

Ceritinib Demonstrates 58% ORR, 7-month PFS in ALK+ NSCLC

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

Breast Cancer Risk Rises To 1 Woman In 9

February 1, 1991

Endoscopic Surgery Provides Equal Or Better Results

September 30, 2005

Improved NCI Relations With FDA Cited As Model For Government Accord, Lasagna Committee Says

April 20, 1990

Study Begins On Link Between Down Syndrome, Leukemia

May 28, 2004

Kurzrock and Ferrara Join UCSD Moores Cancer Center

January 25, 2013

Senate Committee Proposes $100 Million DOD Prostate Cancer Research Program

July 12, 1996